Skip to main content
PMC home page
Molecular Cancer logoLink to Molecular Cancer
. 2024 Apr 2;23:69. doi: 10.1186/s12943-024-01983-3

Correction: CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer

Hongbao Yang 1, Xiaobo Li 2, Qingtao Meng 2, Hao Sun 2, Shenshen Wu 3,4, Weiwei Hu 1, Guilai Liu 1, Xianjing Li 1, Yong Yang 1,5,✉, Rui Chen 2,3,4,✉
PMCID: PMC10985971  PMID: 38566109

Correction: Mol Cancer 19, 13 (2020)

10.1186/s12943-020-1139-3

The authors are writing to request correction to the following paper published in Molecular Cancer [1].

They found Fig. 4D appeared incorrectly, as errors were introduced during preparation of these figures. They thus replace Fig. 4D at 7 days with the correct image, as follow:

Corrected Fig. 4D:

graphic file with name 12943_2024_1983_Fig1_HTML.jpg

In addition, the sequence of primers for circPTK2 should be corrected as follow:

5’- AGAGGAAAGATTTCTGCCCA-3’(forward) and 5’-ATTCCATGTGAACCAGGGTA-3’(reverse).

Footnotes

The online version of the original article can be found at 10.1186/s12943-020-1139-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Yong Yang, Email: yy@cpu.edu.cn.

Rui Chen, Email: ruichen@ccmu.edu.cn.

References

  • 1.Yang H, Li X, Meng Q, et al. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 2020;19:13. doi: 10.1186/s12943-020-1139-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES